BioCardia Signs Agreement With Leading Japanese Pharmaceutical Company for Catheter Biotherapeutic Delivery Product Candidates

Ads

You May Also Like

Ritter Pharmaceuticals, Inc.’s Board Approves 1-for-10 Reverse Stock Split

Los Angeles, California, March 01, 2018 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) ...

ABLYNX PRICES $200 MILLION INITIAL PUBLIC OFFERING IN THE UNITED STATES

REGULATED INFORMATION - INSIDE INFORMATION25 October 2017 - 2 am CEST GHENT, Belgium, 25 ...